Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Potent CETP inhibitors in the Pharmacia pipeline

May 16, 2000

United Therapeutics to begin Flolan-to-Uniprost transition study

May 15, 2000

TP-10 phase I/II study results presented at cardiovascular anesthesiology meeting

May 15, 2000

Chloride channel blockers as novel therapeutic approach to sickle cell disease and other disorders

May 15, 2000

Medinox and Fuso to collaborate on development of new NO-neutralizing drug

May 12, 2000

Actelion announces results from phase III trial in pulmonary hypertension

May 12, 2000

Endovasc obtains funding to advance preclinical testing of NRA

May 12, 2000

Angiotensin II inhibition reduces early atherogenesis in monkeys

May 8, 2000

Approval of new indications for ACE inhibitor recommended by FDA advisory panel

May 4, 2000

Pfizer's new CETP inhibitors claimed for atherosclerosis and associated conditions

May 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...